Munich software for molecule development in drug discovery
| Date | Round | Amount |
|---|---|---|
| May 2022 | Seed Molab.ai, a Munich molecule-development biotech-software startup, raised a low seven-figure round from Picus Capital. | — |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.